Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

If You Invested $1000 In Intuit 10 Years Ago, Here's How Much You Would Have Today

Intuit (NASDAQ:INTU) has outperformed the market over the past 10 years by 9.17% on an annualized basis producing an average annual return of 20.67%. Currently, Intuit has a market capitalization of $104.38 billion.

Benzinga

Here's How Much You Would Have Made Owning Ross Stores Stock In The Last 20 Years

Ross Stores (NASDAQ:ROST) has outperformed the market over the past 20 years by 3.58% on an annualized basis producing an average annual return of 10.26%. Currently, Ross Stores has a market capitalization of $25.52 billion.

Benzinga

Star Equity Holdings's Earnings Outlook

Star Equity Holdings (NASDAQ:STRR) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that Star Equity Holdings will report an earnings per share (EPS) of $-0.15.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Capital Southwest Earnings Preview

Capital Southwest (NASDAQ:CSWC) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that Capital Southwest will report an earnings per share (EPS) of $0.48.

Benzinga

China Automotive Systems's Earnings Outlook

China Automotive Systems (NASDAQ:CAAS) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that China Automotive Systems will report an earnings per share (EPS) of $0.07.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Upgrades

Benzinga

ChromaDex Establishes Joint Venture For Tru Niagen Distribution In China

ChromaDex Corp (NASDAQ:CDXC) has agreed to establish a joint venture through its wholly-owned subsidiary ChromaDex Asia Limited. ChromaDex Asia is expected to assume the distribution agreement with Sinopharm Xingsha relating to the commercialization of Tru Niagen in mainland China and its territories, excluding Hong Kong, Macau, and Taiwan. Also See: ChromaDex Shares Gain On Niagen Supply Pact With…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Expert Ratings for Intuit

Analysts have provided the following ratings for Intuit (NASDAQ:INTU) within the last quarter:

Benzinga

Earnings Preview: Zoom Video Communications

Zoom Video Communications (NASDAQ:ZM) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that Zoom Video Communications will report an earnings per share (EPS) of $0.87.

Benzinga

Looking Into Encore Capital Gr's Return On Invested Capital

According to Benzinga Pro, during Q1, Encore Capital Gr (NASDAQ:ECPG) earned $175.75 million, a 131.0% increase from the preceding quarter. Encore Capital Gr also posted a total of $499.68 million in sales, a 39.85% increase since Q4.

Benzinga

Global Blood Therapeutics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Global Blood Therapeutics's (NASDAQ:GBT) reported sales totaled $55.16 million. Despite a 7.03% increase in earnings, the company posted a loss of $81.42 million.

Benzinga

Upland Software's Return On Capital Employed Overview

Upland Software (NASDAQ:UPLD) brought in sales totaling $78.72 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 205.59%, resulting in a loss of $22.83 million.

Benzinga

Carlyle Group's Return On Capital Employed Overview

Pulled from Benzinga Pro data, Carlyle Group (NASDAQ:CG) posted Q1 earnings of $594.80 million, an increase from Q4 of 9.93%. Sales dropped to $779.50 million, a 58.87% decrease between quarters.

Benzinga

eXp World Holdings Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, eXp World Holdings (NASDAQ:EXPI) earned $8.86 million, a 42.65% increase from the preceding quarter. eXp World Holdings's sales decreased to $1.01 billion, a 6.13% change since Q4.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking Into Morphic Holding's Return On Capital Employed

Benzinga Pro data, Morphic Holding (NASDAQ:MORF) reported Q1 sales of $2.38 million. Earnings fell to a loss of $31.48 million, resulting in a 47.11% decrease from last quarter.

Benzinga

Looking Into Tellurian's Return On Capital Employed

Benzinga Pro data, Tellurian (NASDAQ:TELL) reported Q1 sales of $146.94 million. Earnings fell to a loss of $66.61 million, resulting in a 61.57% decrease from last quarter.

Benzinga

Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Ionis Pharmaceuticals (NASDAQ:IONS) reported Q1 sales of $142.00 million. Earnings fell to a loss of $65.17 million, resulting in a 129.01% decrease from last quarter.

Benzinga

Pacira BioSciences's Return on Invested Capital Overview

Pulled from Benzinga Pro data, Pacira BioSciences (NASDAQ:PCRX) posted Q1 earnings of $6.83 million, an increase from Q4 of 233.1%. Sales dropped to $157.99 million, a 0.76% decrease between quarters.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Vericel Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Vericel (NASDAQ:VCEL) reported Q1 sales of $36.07 million. Earnings fell to a loss of $7.09 million, resulting in a 256.4% decrease from last quarter. Vericel earned $4.53 million, and sales totaled $47.59 million in Q4.

Benzinga

Menarini, Radius Health's Elacestrant Prolongs Progression Free Survival In Breast Cancer

The Menarini Group and Radius Health Inc's (NASDAQ: RDUS) data from the phase 3 EMERALD trial evaluating elacestrant for ER+/HER2- advanced or metastatic breast cancer were published in the Journal of Clinical Oncology.

Benzinga

What's The Future For Cannabis-Infused Edibles?

Cannabis-infused edibles are a booming market. The near-endless array of cannabinoid-rich foods and beverages are coupled with positive sales figures, suggesting that edibles should stick around as a market leader in the years to come.

Benzinga

Why Palo Alto Networks Stock Is Moving Higher

Palo Alto Networks Inc (NASDAQ: PANW) shares are trading higher Friday after the company reported better-than-expected financial results and raised guidance.

Benzinga

Jim Cramer Says This Company Is Losing Money

On CNBC’s "Mad Money Lightning Round," Jim Cramer said PLBY Group, Inc. (NASDAQ: PLBY) is losing money and he doesn’t want to touch companies that are losing money.

Benzinga

Expert Ratings for Costco Wholesale

Analysts have provided the following ratings for Costco Wholesale (NASDAQ:COST) within the last quarter:

Benzinga

Analyst Ratings for Arvinas

Arvinas (NASDAQ:ARVN) has observed the following analyst ratings within the last quarter:

1 … 510 511 512 513

People

Jim Cramer

517 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Zoom Video Communications

45 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.